Download FREE Report Sample
Download Free sampleCisplatin is one of the most commonly used drugs in current combined chemotherapy. Its chemical name is cis-dichlorodiaminoplatin, which is an inorganic metal complex. After chlorine dissociation, it cross-connects with the DNA of cancer cells, thus damaging the function of DNA.It may form intracyclic Chemicalbook or cross-linking with DNA, or it may form cross-linking with DNA and proteins, and inhibit cell mitosis. It is a non-specific drug in cell cycle, which can inhibit lymphocyte transformation in addition to anticancer, has immunosuppressive effect, and can be used as metal complexes for anticancer drugs.
Cisplatin Market contains market size and forecasts of Cisplatin in Global, including the following market information:
Global Cisplatin Market Revenue, 2017-2022, 2023-2028, ($ millions)
Global top five companies in 2021 (%)
The global Cisplatin market was valued at million in 2021 and is projected to reach US$ million by 2028, at a CAGR of % during the forecast period.
The U.S. Market is Estimated at $ Million in 2021, While China is Forecast to Reach $ Million by 2028.
Tablets Segment to Reach $ Million by 2028, with a % CAGR in next six years.
The global key manufacturers of Cisplatin include Eli Lilly and Company, Hospira, Pfizer, Bedford Pharmaceuticals, Alvogen, Athenex Pharmaceutical, Gland Pharma (Fosun Pharma), West-Ward Pharmaceuticals and WG Critical Care, etc. In 2021, the global top five players have a share approximately % in terms of revenue.
We surveyed the Cisplatin companies, and industry experts on this industry, involving the revenue, demand, product type, recent developments and plans, industry trends, drivers, challenges, obstacles, and potential risks.
Total Market by Segment:
Global Cisplatin Market, by Type, 2017-2022, 2023-2028 ($ millions)
Global Cisplatin Market Segment Percentages, by Type, 2021 (%)
Tablets
Injection
Global Cisplatin Market, by Application, 2017-2022, 2023-2028 ($ millions)
Global Cisplatin Market Segment Percentages, by Application, 2021 (%)
Testicular Cancer
Osteosarcoma
Breast Cancer
Global Cisplatin Market, By Region and Country, 2017-2022, 2023-2028 ($ Millions)
Global Cisplatin Market Segment Percentages, By Region and Country, 2021 (%)
North America
US
Canada
Mexico
Europe
Germany
France
U.K.
Italy
Russia
Nordic Countries
Benelux
Rest of Europe
Asia
China
Japan
South Korea
Southeast Asia
India
Rest of Asia
South America
Brazil
Argentina
Rest of South America
Middle East & Africa
Turkey
Israel
Saudi Arabia
UAE
Rest of Middle East & Africa
Competitor Analysis
The report also provides analysis of leading market participants including:
Key companies Cisplatin revenues in global market, 2017-2022 (estimated), ($ millions)
Key companies Cisplatin revenues share in global market, 2021 (%)
Further, the report presents profiles of competitors in the market, key players include:
Eli Lilly and Company
Hospira
Pfizer
Bedford Pharmaceuticals
Alvogen
Athenex Pharmaceutical
Gland Pharma (Fosun Pharma)
West-Ward Pharmaceuticals
WG Critical Care
David Bull Laboratories
Omega Laboratories
Fresenius Kabi
TEVA
Mylan Pharmaceuticals
Yunnan Plant Pharmaceutical
Yunnan Biological Valley Pharmaceutical
Dezhou de Pharmaceutical
Jiangsu Haosen Pharmaceutical Group
Qilu Pharmaceutical
Speak to our Custom Research Team and get the Custom Research in a budget
Custom ResearchFrequently Asked Questions ?
A license granted to one user. Rules or conditions might be applied for e.g. the use of electric files (PDFs) or printings, depending on product.
A license granted to multiple users.
A license granted to a single business site/establishment.
A license granted to all employees within organisation access to the product.
Upto Working 24 to 48 hrs
Upto 72 hrs max - Weekends and Public Holidays
Online Payments with PayPal and CCavenue
Wire Transfer/Bank Transfer
Hard Copy
Industry Market SizeSWOT AnalysisIndustry Major PlayersRevenue ForecastsHistorical and Forecast GrowthProfitability Analysis
